Home
Resources
Product Analysis
Acknowledgements
About
Home
References
Biotech components
Biotech components
Molecule
Products 21 to 30 of 38
Modify Display Properties
Biotech components
Business models
Country of production
Country of distribution
Intended consumer
Date added
Date last modified
Known funding amount
Funding types
Industry
Market status
Organization
Organization type(s)
Product categories
Production process
Source
Trading symbol
Value chain stage
Sort: Title (A-Z)
Date added (oldest-newest)
Date added (newest-oldest)
Date modified (oldest-newest)
Date modified (newest-oldest)
Title (A-Z)
Title (Z-A)
Organization (A-Z)
Organization (Z-A)
Porcupine (synthetic DNA tagging system)
by
University of Washington
Biotech components:
Molecule
Business models:
B2B
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2020/12/18 14:51 (2 years ago)
Date last modified:
2020/12/18 14:51 (2 years ago)
Known funding amount:
N/A
Funding types:
University
Industry:
Multipurpose
+
Novelty
Market status:
Early Stage Concept
Organization type(s):
University
Product categories:
Other
Production process:
N/A
Source:
N/A
Trading symbol:
N/A
Value chain stage:
Input
+
Platform
PRGN-3005: Cancer
by
Intrexon
Biotech components:
Gene Editing
+
Molecule
Business models:
B2B
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/09/12 14:31 (3 years ago)
Date last modified:
2019/09/12 14:31 (3 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Medical
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
Medical Treatment
Production process:
N/A
Source:
Web search
Trading symbol:
XON
(NASDAQ)
Value chain stage:
Finished Product
PRGN-3006: AML and MDS
by
Intrexon
Biotech components:
Gene Editing
+
Molecule
Business models:
B2B
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/09/12 14:32 (3 years ago)
Date last modified:
2019/09/12 14:32 (3 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Medical
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
Medical Treatment
Production process:
N/A
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Finished Product
Project Cyborg
by
Autodesk
Biotech components:
Molecule
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (4 years ago)
Date last modified:
2018/08/30 11:49 (4 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Science
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
Design
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
ADSK
(NASDAQ)
Value chain stage:
Platform
Rapid Trait Development System
by
Cibus
Biotech components:
Molecule
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Research
Date added:
2018/08/30 11:49 (4 years ago)
Date last modified:
2018/10/01 09:18 (4 years ago)
Known funding amount:
70,000,000 USD
Funding types:
Private Funding
Industry:
Food & Agriculture
Market status:
On the market
Organization type(s):
Private Company
Product categories:
Research
Production process:
Closed Production
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Platform
RNA-based Biocontrols
by
Syngenta
Biotech components:
Molecule
Business models:
B2B
Country of production:
Switzerland
Country of distribution:
Switzerland
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (4 years ago)
Date last modified:
2018/10/02 11:25 (4 years ago)
Known funding amount:
2,147,483,647 USD
Funding types:
Shareholder Investment
Industry:
Food & Agriculture
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
Plant
Production process:
Open Release
Source:
NASEM Database
Trading symbol:
SYT
(NYSE)
Value chain stage:
Input
SentryBox
by
Applied DNA Sciences
Biotech components:
Molecule
Business models:
B2C
Country of production:
USA
Country of distribution:
North America
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (4 years ago)
Date last modified:
2019/01/30 12:02 (4 years ago)
Known funding amount:
19,800,000 USD
Funding types:
Shareholder Investment
Industry:
Security
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Forensic Tagging
Production process:
Closed Production
Source:
NASEM Database
Trading symbol:
APDN
(NASDAQ)
Value chain stage:
Finished Product
SER150DN
by
Serodus
+
Evolva
Biotech components:
Molecule
Business models:
B2B
Country of production:
USA
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2018/08/30 11:49 (4 years ago)
Date last modified:
2018/11/09 16:29 (4 years ago)
Known funding amount:
102,000,000 NOK
Funding types:
Private Funding
Industry:
Health
Market status:
Under Development
+
More information needed
Organization type(s):
Private Company
Product categories:
Medical Treatment
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
N/A
Value chain stage:
Finished Product
SigNature DNA
by
Applied DNA Sciences
Biotech components:
Molecule
Business models:
B2C
Country of production:
USA
Country of distribution:
USA
+
Turkey
+
Africa
+
UK
Intended consumer:
Commercial
+
Government
Date added:
2018/08/30 11:49 (4 years ago)
Date last modified:
2019/01/30 12:01 (4 years ago)
Known funding amount:
19,800,000 USD
Funding types:
Shareholder Investment
Industry:
Security
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Forensic Tagging
Production process:
Closed Production
Source:
NASEM Database
Trading symbol:
APDN
(NASDAQ)
Value chain stage:
Finished Product
SigNature T
by
Applied DNA Sciences
Biotech components:
Molecule
Business models:
B2C
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (4 years ago)
Date last modified:
2019/01/30 12:00 (4 years ago)
Known funding amount:
19,800,000 USD
Funding types:
Shareholder Investment
Industry:
Security
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Forensic Tagging
Production process:
Closed Production
Source:
NASEM Database
Trading symbol:
APDN
(NASDAQ)
Value chain stage:
Finished Product
1
2
3
4
Login
or
register
to add and edit products
Future
Bioengineered
Products
Home
Resources
Product Analysis
Acknowledgements
About
